SCHEDULE 13G/AAccepted Feb 17, 5:17 PM ET
Keros Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
5:17 PM
Feb 17, 2026
Filed
Feb 17, 2026
Documents
2
Size
18.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.